The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions.
Additionally, this aim will be partially delivered, since the assay lacked the sensitivity required for measuring CMV-Hb in single erythrocytes and SE-MALDI could not be used to enhance throughput (see aim 2 and 3)
The testing material was applied to both scarified and non-scarified skin on the flank (0.5 ml on a 6 cm2 area, with hair clipped) under an occlusive hypoallergenic dressing for 24 hours
TB-500 (Thymosin Beta-4): The Closest Competitor TB-500, a synthetic fragment of thymosin beta-4, is the peptide most frequently compared to BPC-157
Clinicians presently recommend aiming for the lowest effective dose and administering the peptide at about 600mg/weekly, split into six injections throughout the week